Last reviewed · How we verify

NCT04087824

Deep Learning Algorithm for Recognition of Colonic Segments.

Status unknown NA Last updated 12 September 2019
What this trial tests

NA trial testing AI assisted recognition of colonic segments in Colonic Diseases in 60 participants. Status unknown.

Timeline
15 September 2019
Primary endpoint
15 November 2019
15 December 2019

Quick facts

Lead sponsorShandong University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment60
Start date15 September 2019
Primary completion15 November 2019
Estimated completion15 December 2019

Drugs / interventions tested

Conditions studied

Sponsor

Shandong University

Who can join

Adults 18 to 70, any sex, with Colonic Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to develop and validate a deep learning algorithm to realize automatic recognition of colonic segments under conventional colonoscopy. Then, evaluate the accuracy this new artificial intelligence(AI) assisted recognition system in clinic practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Colonic Diseases

Currently open trials in the same condition.

Other Shandong University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04087824.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing